Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$23.02 +0.12 (+0.53%)
As of 02:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

WRBY vs. STVN, GKOS, BLCO, NARI, IRTC, TMDX, SLNO, INSP, NVST, and PRCT

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Warby Parker (NYSE:WRBY) and Stevanato Group (NYSE:STVN) are both mid-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

In the previous week, Warby Parker had 9 more articles in the media than Stevanato Group. MarketBeat recorded 12 mentions for Warby Parker and 3 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.04 beat Warby Parker's score of 0.02 indicating that Stevanato Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Stevanato Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$771.32M3.12-$20.39M-$0.12-191.84
Stevanato Group€1.19B6.60€127.45M€0.5151.04

Warby Parker currently has a consensus price target of $22.88, suggesting a potential downside of 0.63%. Given Warby Parker's higher possible upside, analysts plainly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
9 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.53
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86

93.2% of Warby Parker shares are held by institutional investors. 18.2% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Warby Parker has a beta of 2.09, suggesting that its stock price is 109% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.

Stevanato Group has a net margin of 11.14% compared to Warby Parker's net margin of -1.79%. Stevanato Group's return on equity of 10.00% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker-1.79% -2.48% -1.29%
Stevanato Group 11.14%10.00%6.03%

Summary

Stevanato Group beats Warby Parker on 11 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.41B$33.11B$16.11B$20.62B
Dividend YieldN/A2.63%3.13%3.65%
P/E Ratio-192.5132.1119.7027.22
Price / Sales3.121.8245.8553.72
Price / Cash67.7816.3514.7222.28
Price / Book6.878.386.034.59
Net Income-$20.39M$1.19B$691.68M$995.22M
7 Day Performance3.33%-1.66%1.54%-1.00%
1 Month Performance5.85%1.12%1.03%3.35%
1 Year Performance33.65%30.53%3.69%7.07%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
2.4539 of 5 stars
$23.02
+0.5%
$22.88
-0.6%
+40.5%$2.41B$771.32M-192.513,780
STVN
Stevanato Group
N/A€24.23
-1.5%
N/A+21.0%€7.34B€1.19B47.515,521Positive News
GKOS
Glaukos
4.3297 of 5 stars
$101.69
-1.7%
$134.67
+32.4%
-20.2%$5.91B$383.48M-42.91780Analyst Forecast
BLCO
Bausch + Lomb
3.0186 of 5 stars
$13.83
-0.4%
$15.54
+12.4%
-13.4%$4.91B$4.79B-13.4313,500
NARI
Inari Medical
0.2615 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.0132 of 5 stars
$139.22
-2.3%
$138.60
-0.4%
+35.8%$4.55B$591.84M-44.342,000Analyst Forecast
TMDX
TransMedics Group
2.26 of 5 stars
$125.17
-3.1%
$127.33
+1.7%
-19.9%$4.37B$441.54M92.04210Positive News
Analyst Forecast
SLNO
Soleno Therapeutics
4.5814 of 5 stars
$85.27
-1.6%
$107.10
+25.6%
+66.5%$4.37BN/A-18.4630
INSP
Inspire Medical Systems
4.8604 of 5 stars
$127.11
-1.1%
$211.91
+66.7%
-7.8%$3.79B$802.80M58.581,246Positive News
Analyst Forecast
NVST
Envista
3.3623 of 5 stars
$19.66
-3.6%
$20.23
+2.9%
+24.2%$3.46B$2.51B-3.0112,300Analyst Revision
PRCT
PROCEPT BioRobotics
2.485 of 5 stars
$56.97
-1.6%
$90.00
+58.0%
-13.2%$3.20B$249.12M-33.51430News Coverage
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners